Get the Stockscreener App
39.01
3.53%
1.33
Tonix Pharmaceuticals Holding Corp stock is traded at $39.01, with a volume of 1.27M.
It is up +3.53% in the last 24 hours and up +4.58% over the past month.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
See More
Previous Close:
$37.68
Open:
$35.72
24h Volume:
1.27M
Relative Volume:
1.17
Market Cap:
$287.00M
Revenue:
-
Net Income/Loss:
$-121.02M
P/E Ratio:
-3.4645
EPS:
-11.26
Net Cash Flow:
$-114.09M
1W Performance:
-21.55%
1M Performance:
+4.58%
6M Performance:
-8.88%
1Y Performance:
-23.58%
1-Day Range:
$35.66
$39.60
1-Week Range:
$35.66
$50.39
52-Week Range:
$7.31
$130.00
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Company Profile
Name
Tonix Pharmaceuticals Holding Corp
Sector
Industry
Phone
212-980-9155
Address
26 MAIN STREET, SUITE 101, CHATHAM, NY
Compare TNXP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNXP
Tonix Pharmaceuticals Holding Corp
|
39.01 | 277.22M | 0 | -121.02M | -114.09M | -11.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-18-22 | Initiated | Noble Capital Markets | Outperform |
| Apr-18-19 | Upgrade | ROTH Capital | Neutral → Buy |
| Aug-18-17 | Upgrade | ROTH Capital | Neutral → Buy |
| Sep-07-16 | Downgrade | ROTH Capital | Buy → Neutral |
| Feb-17-16 | Reiterated | Oppenheimer | Outperform |
| Nov-04-15 | Initiated | Cantor Fitzgerald | Buy |
| Jun-12-15 | Initiated | Oppenheimer | Outperform |
| Feb-17-15 | Reiterated | ROTH Capital | Buy |
| Sep-29-14 | Reiterated | ROTH Capital | Buy |
View All
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Latest News
Why is Tonix Pharmaceuticals Holding Corp. stock attracting strong analyst attentionWealth Building Opportunities For Beginners - jammulinksnews.com
What are the technical indicators suggesting about Tonix Pharmaceuticals Holding Corp.Chart Pattern Report Backed By Experts - jammulinksnews.com
What institutional investors are buying Tonix Pharmaceuticals Holding Corp. stockSmart Portfolio Signals To Watch Now - jammulinksnews.com
Key resistance and support levels for Tonix Pharmaceuticals Holding Corp.Early Entry Picks Before News Breakout Reviewed - metal.it
Tonix launches Move Fibro Forward campaign to support millions living with Fibromyalgia - Proactive financial news
Price Channel Expanding on Tonix Pharmaceuticals Holding Corp.’s ChartLow Risk Swing Trade Opportunities Identified - metal.it
TNXP: 2Q25 Financial Update and Deep Dive Into TNX-1500 - Smartkarma
Published on: 2025-07-29 17:18:40 - metal.it
TNXP: 2Q25 Financial Update and Deep Dive Into TNX-1500… - Yahoo Finance
Published on: 2025-07-29 07:17:10 - metal.it
Should I hold or sell Tonix Pharmaceuticals Holding Corp. stock in 2025Expert Picks Report For Fast Growth - jammulinksnews.com
How volatile is Tonix Pharmaceuticals Holding Corp. stock compared to the marketAdvanced Screener Planner For Consistent Profits - jammulinksnews.com
How does Tonix Pharmaceuticals Holding Corp. compare to its industry peersInvest smarter with real-time trading alerts - jammulinksnews.com
Is Tonix Pharmaceuticals Holding Corp. a growth stock or a value stockTop Growth Entry Points With Low Risk - jammulinksnews.com
What are Tonix Pharmaceuticals Holding Corp. company’s key revenue driversBreakthrough financial growth - jammulinksnews.com
What is the risk reward ratio of investing in Tonix Pharmaceuticals Holding Corp. stockDiscover high-impact stocks for your portfolio - jammulinksnews.com
Is Tonix Pharmaceuticals Holding Corp. stock overvalued or undervaluedBuild a portfolio that outperforms consistently - jammulinksnews.com
Does Tonix Pharmaceuticals Holding Corp. stock perform well during market downturnsGet daily expert analysis on top stocks - jammulinksnews.com
What makes Tonix Pharmaceuticals Holding Corp. stock price move sharplyHigh-return market picks - jammulinksnews.com
When is Tonix Pharmaceuticals Holding Corp. stock expected to show significant growthFastest-growing stock picks - jammulinksnews.com
Why Tonix Pharmaceuticals Holding Corp. stock is on top investor watchlistsFree Market Dynamics Reports - metal.it
Published on: 2025-07-26 12:35:26 - metal.it
Tonix Pharmaceuticals Holding Corp. Stock Analysis and ForecastUnprecedented growth rates - PrintWeekIndia
Tonix Pharma’s Unexpected Rise in Stock Value - timothysykes.com
Is TNXP Stock Ready for Takeoff? - StocksToTrade
Is Tonix Pharmaceuticals Holding Corp. a good long term investmentAccelerated profit realization - PrintWeekIndia
What drives Tonix Pharmaceuticals Holding Corp. stock priceHigh-yield market plays - PrintWeekIndia
What analysts say about Tonix Pharmaceuticals Holding Corp. stockFree High-Return Strategy Alerts - PrintWeekIndia
CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight - The Malaysian Reserve
Tonix Pharmaceuticals shares rise 2.00% premarket after launching Move Fibro Forward campaign for fibromyalgia awareness. - AInvest
Tonix Pharmaceuticals Announces the Launch of the “Move - GlobeNewswire
Tonix Pharma Launches Move Fibro Forward Campaign - TipRanks
Tonix Tackles 15-Year Fibromyalgia Treatment Void with Groundbreaking Patient Support Campaign - Stock Titan
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):